Asset
Nebokitug
Chemomab Therapeutics Ltd. American Depositary Share
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06037577 | phase1 | completed | 2019-03-05 | 2019-05-05 | ChemomAb Ltd. | Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects |
FDA applications (0)
This company has no applications containing this asset.